Patent details
EP2248822
Title:
Meningococcus adhesins
Basic Information
- Publication number:
- EP2248822
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP100056852
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Meningococcus adhesins
- French Title of Invention:
- Adhésines de Meningococcus
- German Title of Invention:
- Meningokokken Adhaesine
- SPC Number:
-
Dates
- Filing date:
- 26/07/2002
- Grant date:
- 23/11/2016
- EP Publication Date:
- 23/11/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/11/2010
- EP B1 Publication Date:
- 23/11/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/07/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/07/2002
-
-
- Name:
- GlaxoSmithKline Biologicals SA
- Address:
- Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
Agent
- Name:
- KIRKPATRICK SA / NV
- From:
- 02/02/2017
- Address:
- AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
- To:
Inventor
1
- Name:
- Comanducci Maurizio
- Address:
- Italy (IT)
2
- Name:
- Arico Maria
- Address:
- Italy (IT)
Priority
1
- Priority Number:
- 0118401
- Priority Date:
- 27/07/2001
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0121591
- Priority Date:
- 06/09/2001
- Priority Country:
- United Kingdom (GB)
3
- Priority Number:
- 0211025
- Priority Date:
- 14/05/2002
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
-
C07K 14/22;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 25/06/2021
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)